Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 423
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03703596 | Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC | ||
| NCT04809142 | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer | ||
| NCT06702618 | Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer | ||
| NCT06089278 | A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps. | ||
| NCT04398940 | A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer | ||
| NCT02287857 | Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B | ||
| NCT06438783 | TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors | ||
| NCT05987358 | A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma. | ||
| NCT04481607 | A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets | ||
| NCT06413953 | A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors | ||
| NCT07269145 | A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors | ||
| NCT07083739 | A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults | ||
| NCT06160895 | A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects | ||
| NCT04373395 | Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML) | ||
| NCT04180150 | A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B | ||
| NCT06644417 | Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection | ||
| NCT06344351 | A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer | ||
| NCT03790228 | Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC | ||
| NCT03983928 | Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer | ||
| NCT04325776 | A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis | ||
| NCT02574819 | Study of Methylnaltrexone in Opioid-Induced Constipation Patients | ||
| NCT06566248 | A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B | ||
| NCT04842526 | Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study | ||
| NCT04344158 | A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) | ||
| NCT07291050 | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors | ||
| NCT04846634 | Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043) | ||
| NCT05306847 | Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer | ||
| NCT07165951 | Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | ||
| NCT07327281 | A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects | ||
| NCT04234607 | A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) | ||
| NCT05011019 | A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis | ||
| NCT05400876 | To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma | ||
| NCT06829771 | Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma | ||
| NCT04324879 | A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL) | ||
| NCT04009317 | Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT05145218 | A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer | ||
| NCT04236362 | A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer | ||
| NCT04111913 | A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer | ||
| NCT06672276 | To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency | ||
| NCT05607446 | To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis | ||
| NCT01926288 | Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B | ||
| NCT03453034 | Tolerance and Pharmacokinetics of TQ-B3233 | ||
| NCT05894421 | TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers | ||
| NCT05193604 | A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | ||
| NCT04337879 | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer | ||
| NCT04073537 | Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer | ||
| NCT06522945 | To Evaluate the Pharmacokinetics and Safety of TQD3524 for Injection in Renal Impairment Subjects | ||
| NCT06500091 | TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors | ||
| NCT07052097 | Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis | ||
| NCT05815862 | Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer |
